Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is taken once a week, on the same day each week, by subcutaneous injection. That cadence is fixed by the medicine's design: the half-life of tirzepatide means a seven-day interval keeps levels steady enough to work without the peaks and troughs of more frequent dosing. These are prescription-only medicines assessed individually by a prescriber; frequency is never something to adjust on your own.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's a reasonable assumption, more medicine, faster results. But tirzepatide's once-weekly schedule isn't a minimum; it's a ceiling. The molecule is engineered with a fatty-acid chain that binds to albumin in the bloodstream, extending its active life to roughly five to seven days. Injecting twice a week wouldn't double the effect; it would stack blood levels beyond what the doses are calibrated for and significantly increase the risk of side effects, particularly the nausea, vomiting and diarrhoea that the slow titration schedule is specifically designed to limit.
The NHS patient information for tirzepatide is clear that the injection is given once a week. If you find yourself wondering whether injecting more frequently would help, that's genuinely worth raising with a prescriber, but the answer will be no, and the reason matters as much as the instruction.
Understanding why the schedule is fixed also helps on the weeks the medicine feels like it isn't doing much. The therapeutic effect builds gradually over months of consistent weekly dosing, not overnight.
Mounjaro is licensed as a once-weekly injection, and consistency of timing matters more than the specific day you pick. Most people choose whatever day fits their routine (Sunday evening, Wednesday morning) and stick to it. If you order by noon on a weekday and your delivery arrives the next working day, you have plenty of time to plan your injection day before the pen goes in the fridge door.
The flexibility question that comes up most often is whether you can shift your injection day. You can, once, if you need to, provided the gap between two consecutive injections is at least 72 hours. Beyond that one-off shift, the weekly rhythm resumes. This isn't a rule to play around with; it's documented in the Mounjaro SmPC on the eMC, and your prescriber or pharmacist can walk you through it if your schedule genuinely needs to change.
If you're thinking about what Mounjaro costs per month and how that lines up with one pen per four weeks, the Mounjaro pricing page sets out the private market context clearly, including what a legitimate prescription should include.
Both situations are worth knowing before they happen. Injecting early (say, five days into a seven-day cycle because you're going on holiday) is too close together. The guidance requires a minimum of three days (72 hours) between injections, and our page on how often you can take tirzepatide explains why that lower limit exists and what happens to blood levels when it isn't respected.
Missing a dose entirely is the more common scenario. If you remember within four days of your usual injection day, take it as soon as you remember and then return to your normal weekly schedule. If it's been more than four days, skip that dose and inject on your next scheduled day as planned. Never take two doses to compensate. The Patient Information Leaflet spells this out; your prescriber at our clinical team is there if you're unsure what applies to your situation.
These details matter because tirzepatide's side-effect profile (which runs mostly to gastrointestinal symptoms) is at its most noticeable when blood levels shift suddenly. Consistency is what keeps those effects manageable for most people.
Starting at 2.5 mg isn't about weight loss, that starting strength exists to give your system time to adjust before the therapeutic doses begin. The schedule then progresses in 4-week steps (2.5 mg, 5 mg, 7.5 mg, and so on up to 15 mg) under prescriber guidance, based on how you're tolerating each level.
Throughout every stage, the injection frequency stays the same: once a week. What changes is the strength, not the cadence. This is why the question of how often Mounjaro is taken has a consistent answer regardless of which dose you're on, and if you want more detail on the dosing rhythm itself, our page on how often Mounjaro is taken across the treatment course covers the full picture, including what to expect at each titration stage. Separately, if you've ever wondered how often you use Mounjaro in practical terms, including pen handling and storage between weekly doses, that page walks through the everyday routine. For a broader overview of tirzepatide and how it works across the full treatment journey, the tirzepatide information page covers the dual GIP and GLP-1 mechanism and the clinical evidence behind it.
NICE's appraisal of tirzepatide (TA1026) notes that if someone hasn't achieved at least 5% weight loss after six months at the highest tolerated dose, continuing is reviewed. That review happens with a prescriber, not by adjusting how often you inject.
If you'd like a prescriber to assess whether Mounjaro is clinically suitable for you, speak to our prescribers through a free consultation, reviewed the same day by a real clinician, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.